Why cancer at the primary site and in the lymph nodes contributes to the risk of cancer death

Cancer

Volumn 115, Issue 21, 2009, Pages 5084-5094

  Michaelson, James S ^a,b   Chen, L Leon ^a   Silverstein, Melvin J ^c   Cheongsiatmoy, Justin A ^a   Mihm Jr , Martin C ^a,b   Sober, Arthur J ^a,b   Tanabe, Kenneth K ^a,b   Smith, Barbara L ^a,b   Younger, Jerry ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

Author keywords

Breast cancer; Cancer death; Lymph node status; Melanoma; Metastasis; Prediction; Risk; Tumor size

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CELL; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; HUMAN; LETHALITY; LYMPH NODE; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS; NEOPLASM; PRIMARY TUMOR; PRIORITY JOURNAL; RISK; TUMOR VOLUME;

HUMANS; LYMPHATIC METASTASIS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASMS; RISK ASSESSMENT; TUMOR BURDEN;

EID: 70350516031     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24542     Document Type: Article

References (20)

1. Michaelson JS, Silverstein M, Wyatt J, et al. Predicting the survival of patients with breast carcinoma using tumor size. Cancer. 2002;95:713-723. (Pubitemid 34839661)
2. Michaelson JS, Satija S, Kopans D, et al. Gauging the impact of breast carcinoma screening in terms of tumor size and death rate. Cancer. 2003;98:2114-2124. (Pubitemid 37392414)
3. Michaelson JS, Cheongsiatmoy JA, Dewey F, et al. Spread of human cancer cells occurs with probabilities indicative of a nongenetic mechanism. Br J Cancer. 2005;93:1244-1249. (Pubitemid 41679410)
4. Michaelson JS, Chen LL, Silverstein MJ, et al. How cancer at the primary site and in the nodes contributes to the risk of cancer death. Cancer. 2009;115:000-000
5. Michaelson JS, Silverstein M, Sgroi D, et al. The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer. 2003;98:2133-2143. (Pubitemid 37392416)
6. Michaelson J. The role of molecular discreteness in normal and cancerous growth. Anticancer Res. 1999;19:4853-4867. (Pubitemid 30093494)
7. Temple CF, Huchcroft SA, Hurlbut DJ, Davidson JS. Histologic staging in malignant melanoma: cross-sectional area revisited. J Surg Oncol. 1998;69:83-87.
8. Bernards R, Weinberg RA. A progression puzzle. Nature. 2002;418:823-823
9. Cifone MA, Fidler IJ. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci U S A. 1981;78:6949-6952.
10. Fidler IJ. The Ernst W. Bertner Memorial Award Lecture: the evolution of biological heterogeneity in metastatic neoplasms. Symp Fundam Cancer Res. 1983;36:5-26.
11. Couzin J. A clash over genes that foretell metastasis [serial online]. Science. 2003;299:1005.
12. Yokota J. Tumor progression and metastasis. Carcinogenesis. 2000;21:497-503.
13. Sobel ME. Metastasis suppressor genes. J Natl Cancer Inst. 1990;82:267-276.
14. Welch DR, Steeg PS, Rinker-Schaeffer CW. Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis. Breast Cancer Res. 2000;2:408-416.
15. Bernards R. Cancer: cues for migration. Nature. 2003;425: 247-248.
16. Van't Veer LJ, Weigelt B. Road map to metastasis. Nat Med. 2003;9:999-1000.
17. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117:927-939. (Pubitemid 38798858)
18. Halsted WS. The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 1907;46:1-19.
19. Fisher B. Laboratory and clinical research in breast cancer - a personal adventure: the David A. Karnofsky Memorial Lecture. Cancer Res. 1980;40:3863-3874.
20. Hellman S. Natural history of small breast cancers. J Clin Oncol. 1994;12:2229-2234. (Pubitemid 24356043)